Anal HSIL clinical trials at UCSF

1 research study open to eligible people

Showing trials for

  • CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial

    open to eligible people ages 21 years and up

    This study is focused on treatment of anal high-grade squamous intraepithelial lesions (HSIL) in persons with HIV (PWH), with the ultimate goal of applying the approach toward prevention of anal cancer in this population

    San Francisco, California and other locations

Our lead scientists for Anal HSIL research studies include .

Last updated: